Aptevo Therapeutics Inc.

Nasdaq:APVO

Pharmaceutical Preparations·SEATTLE, WA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	2/14/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

17 shown

Filed	Period
11/6/25	Q4 FY2025	→
8/11/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
4/28/25	Q1 FY2025	→
2/14/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

63 shown

Filed	Type	Description
2/19/26	Vote	Submission of Matters to a Vote of Security Holders	→
2/3/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/9/26	Agreement	Entry into a Material Definitive Agreement	→
12/29/25	Other	Amendments to Articles of Incorporation or Bylaws	→
12/9/25	Other	8-K Filing	→
10/30/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/30/26	424B4	424B4	→
1/28/26	S-1	S-1	→
11/25/25	424B4	424B4	→
10/1/25	S-1	S-1	→
8/8/25	424B4	424B4	→
7/25/25	S-1	S-1	→
↓

Filing History(689 filings)

TypeDateAccessionPeriodSize

8-K

Feb 19, 2026

0001193125-26-0577078-K

Feb 18, 2026

167.6 KB

SCHEDULE 13G/A

Feb 17, 2026

0000902664-26-001127

—

10.8 KB

SCHEDULE 13G/A

Feb 17, 2026

0001649553-26-000020

—

11.5 KB

8-K

Feb 3, 2026

0001193125-26-0344738-K

Jan 30, 2026

212.5 KB

EFFECT

Jan 30, 2026

9999999995-26-000430

—

1.7 KB

424B4

Jan 30, 2026

0001193125-26-032011424B4

—

390.3 KB

S-1

Jan 28, 2026

0001193125-26-027200S-1

—

1.3 MB

DEF 14A

Jan 26, 2026

0001193125-26-022560DEF 14A

Jan 23, 2026

1.0 MB

PRE 14A

Jan 16, 2026

0001193125-26-015339PRE 14A

Jan 16, 2026

1.6 MB

8-K

Jan 9, 2026

0001193125-26-0083188-K

Jan 8, 2026

684.3 KB

8-K

Dec 29, 2025

0001193125-25-3354978-K

Dec 29, 2025

182.4 KB

8-K

Dec 9, 2025

0001193125-25-3129728-K

Dec 9, 2025

209.5 KB

EFFECT

Nov 25, 2025

9999999995-25-003381

—

1.7 KB

424B4

Nov 25, 2025

0001193125-25-297513424B4

—

394.7 KB

Nov 12, 2025

0001193125-25-2777714

Nov 10, 2025

4.2 KB

SCHEDULE 13G/A

Nov 7, 2025

0000070858-25-000408

—

108.1 KB

10-Q

Nov 6, 2025

0001193125-25-26959810-Q

Sep 30, 2025

7.1 MB

8-K

Nov 6, 2025

0001193125-25-2694708-K

Nov 6, 2025

396.7 KB

8-K

Oct 30, 2025

0001193125-25-2586658-K

Oct 30, 2025

190.7 KB

SCHEDULE 13G

Oct 6, 2025

0000070858-25-000377

—

108.0 KB

Oct 3, 2025

0000070858-25-000374PRIMARY DOCUMENT

Oct 1, 2025

10.0 KB

Oct 3, 2025

0000070858-25-000373PRIMARY DOCUMENT

Sep 30, 2025

12.0 KB

S-1

Oct 1, 2025

0001193125-25-226825S-1

—

1.3 MB

SCHEDULE 13G

Sep 17, 2025

0000902664-25-004113

—

16.7 KB

8-K

Sep 16, 2025

0001193125-25-2051078-K

Sep 16, 2025

205.0 KB

25 filings shown

Aptevo Therapeutics Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(689 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/26/26	DEF 14A	DEF 14A	→
1/16/26	PRE 14A	PRE 14A	→
7/3/25	DEF 14A	DEF 14A	→
6/23/25	PRE 14A	PRE 14A	→
4/25/25	DEF 14A	DEF 14A	→
4/10/25	PRE 14A	PRE 14A	→
↓

Filed	Form	Description
11/12/25	4	4	→
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	3	PRIMARY DOCUMENT	→
8/8/25	4	4	→
8/8/25	4	4	→
8/8/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/30/26	EFFECT	EFFECT	→
11/25/25	EFFECT	EFFECT	→
11/7/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/6/25	SCHEDULE 13G	SCHEDULE 13G	→
↓